Insights

Dr Peter Kaiser, an ophthalmologist, provides an overview of biosimilars, the regulatory pathway for their approval, and how biosimilars can aid in providing quality care to patients. Dr. Kaiser shares data with ranibizumab biosimilars in ophthalmology and discusses key differences between biosimilar and reference product studies.

Experts in gastroenterology discuss recent updates in the management of ulcerative colitis, highlighting their respective approaches to treatment.

An expert in emergency medicine reviews recent publications examining the efficacy and cost of prescription treatments in the management of opioid induced constipation.

Jerry Bagel, MD, MS, discusses the management of moderate-to-severe plaque psoriasis with a focus on newer agents currently in the drug approval pipeline.

An expert dermatologist provides insight on approaching the optimal treatment and management of vitiligo.

Experts in pulmonology provide insight on the diagnosis and optimal management of idiopathic pulmonary fibrosis (IPF).

Theresa R. Cerulli, MD, discusses current therapy options for the management of attention deficit hyperactivity disorders in the pediatric population.

Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger, DO, MSPH; and John J. Strouse, MD, PhD, explore current therapy options for the management of sickle cell disease and discuss the impact of anemia and hemolysis.

A key opinion leader in neurology, Arun S. Varadhachary, MD, PhD, reviews the case of a 28-year-old with spinal muscular atrophy and considers the role of nusinersen for patients with later-onset SMA.

Expert rheumatologist, Kostas N. Botsoglou, MD provides an overview of the current therapeutic landscape for Systemic Autoimmune Rheumatic Diseases (SARDs) and discusses potential treatments on the horizon.